The storied success of copyright’s flagship drug has undeniably influenced the pharmaceutical landscape. However, putting money in companies heavily reliant on generic versions and the waning patent https://bookmarkcolumn.com/story21177106/the-blue-pill-and-pharmaceutical-companies-a-risky-venture